Advocacy update
The Advocacy Update is a weekly advocacy newsletter that provides brief political and regulatory news and AADA’s advocacy activity updates. Delivered weekly to members’ email, Advocacy Update provides news that affects dermatology including federal and state policy, legislation and political action, and economic and regulatory affairs. In addition, AAD members receive special news alerts throughout the year when advocacy news breaks.
Recent issues
As a direct result of AADA advocacy, Payer win: BCBS Michigan pauses its modifier 25 payment reduction policy.
The AADA scores a win with the New Hampshire governor’s vetoes of optometric scope expansion.
The AADA urged the FDA to reconsider its withdrawal of the proposed indoor sunlamp regulation.
The Academy’s recent statement on the FDA’s withdrawal of a proposed rule on sunlamp regulation drove media coverage, encouraging the FDA to reconsider this action.
The AADA continues to encourage the FDA to implement the updated changes to the iPLEDGE REMS program.
We asked Medicare to update the new guidelines for patch testing to reflect current literature and accept professional testing standards for certain allergy testing.
Advocacy news alerts
A new bill in the House would boost physician payments by blunting budget neutrality.
FDA finally confirms iPLEDGE changes long advocated for by AADA.
The FDA has proposed the first new sunscreen active ingredient, called BEMT, in 26 years.
See past issues of the weekly Advocacy Update newsletter.
